Report me for selling fake medicine? Why are you crying when your illness relapses?

At this time, Bingbing suddenly asked this question.

This issue is also very popular and is popular among the public.

How does Chen Xuan judge the current value of lung cancer-specific drugs, and how is it different from before?

This question also lets everyone know the true value of the special medicine for lung cancer, so that people no longer think that his previous words were bragging.

"At that time, I was indeed willing to sell the formula for 1000 billion."

"Because with 1000 billion, I can start many projects at the same time and achieve my goals faster."

"It's just a drug patent. If selling it can get more development resources and save more time, I'm willing to do it."

Chen Xuan said calmly, "But it's impossible now. You can't expect to buy this formula with 1000 billion now. I believe you wouldn't do that if it were you, right?"

She did not shy away from this question at all.

When the lung cancer drug was just beginning clinical trials, he did consider selling the formula.

If a pharmaceutical company offered 1000 billion at that time, he would be very happy to sell the formula of the lung cancer drug directly.

Although he believes that the future revenue from the lung cancer drug will definitely be more than 1000 billion, it does not prevent him from being willing to transfer the drug patent.

Simply because the time cost is also very valuable, and considering the conversion rate of time, it is better to directly sell the formula patent, which can actually allow him to obtain greater benefits.

He can get 1000 billion directly, which will save him a lot of trouble.

But now it is impossible,

After all, effective drugs for lung cancer are already available on the market. Just in China, sales have received orders exceeding 600 billion yuan in four years.

If we add overseas markets, it won’t take long for us to generate hundreds of billions of dollars in revenue.

The most important thing is that once the specific drug for lung cancer is on the market, Chen Xuan will not need to invest any energy.

In this way, the so-called time cost cannot be directly reflected. If it is transferred for hundreds of billions now, it is obviously not cost-effective.

"Hiss, that sounds really awesome, but there's nothing wrong with it."

"If it were me, I would still agree. This is 1000 billion, which will directly put me at the top of the rich list."

"1000 billion is enough to be considered super-rich on the global rich list, but Chen Xuan said it so casually."

"If it were me, I wouldn't sell the formula. Maybe China alone would make more than 1000 billion in profit."

"That's right. The Chinese market is worth more than 100 billion, plus the even larger overseas market. Selling for 200 billion or 300 billion wouldn't be a problem. Who would want to sell for 100 billion?"

"Those who say they'll sell it for 1000 billion are so short-sighted. Fortunately, the formula isn't in your hands."

"Before clinical trials, 1000 billion yuan was certainly no problem, but now that it has been approved for marketing, it is simply a pipe dream to want to spend 1000 billion yuan to acquire it."

No one objected to Chen Xuan's words.

Although 1000 billion sounds exaggerated, the number is too shocking.

But they also know that the current patent for lung cancer drugs is definitely worth far more than 1000 billion yuan.

After it was approved for listing and generated sales of more than 600 billion yuan as soon as it was listed, it would be impossible to buy this patent for 1000 billion yuan.

So, there is nothing wrong with him saying this now.

"Mr. Chen, you mean that you might be able to sell the drug patent."

"If you are willing to transfer the patent, what is the approximate price you would like to receive for transferring the patent for your lung cancer drug?"

At this time, the other reporters at the scene also took the opportunity to ask further questions.

If Bingbing asked similar questions, it was to make Chen Xuan prove that what he said before was true.

But the problem with this reporter is that he was helping other pharmaceutical companies to gather information.

Now that lung cancer drugs are so popular, these pharmaceutical companies will definitely come up with this idea again. Even if it is 1000 billion, they will definitely be tempted.